Apollo Medical Statistics Share Statistics Apollo Medical has 44.84M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 44.84M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 34.19M Failed to Deliver (FTD) Shares 823 FTD / Avg. Volume 0.39%
Short Selling Information The latest short interest is 2.8M, so 0% of the outstanding
shares have been sold short.
Short Interest 2.8M Short % of Shares Out n/a Short % of Float 8.06% Short Ratio (days to cover) 20.62
Valuation Ratios The PE ratio is 43.69 and the forward
PE ratio is 16.53.
Apollo Medical's PEG ratio is
-1.46.
PE Ratio 43.69 Forward PE 16.53 PS Ratio 0.93 Forward PS 0.8 PB Ratio 2.65 P/FCF Ratio 42.68 PEG Ratio -1.46
Financial Ratio History Enterprise Valuation Apollo Medical has an Enterprise Value (EV) of 1.76B.
EV / Sales 0.87 EV / EBITDA 25.58 EV / EBIT 33.75 EV / FCF 39.88
Financial Position The company has a current ratio of 1.43,
with a Debt / Equity ratio of 0.05.
Current Ratio 1.43 Quick Ratio 1.43 Debt / Equity 0.05 Debt / EBITDA 0.51 Debt / FCF 0.8 Interest Coverage -2.7
Financial Efficiency Return on Equity is 6.05% and Return on Invested Capital is 7.68%.
Return on Equity 6.05% Return on Assets 4.6% Return on Invested Capital 7.68% Revenue Per Employee $1.49M Profits Per Employee $31.68K Employee Count 1,362 Asset Turnover 2.17 Inventory Turnover n/a
Taxes Income Tax 30.89M Effective Tax Rate 38.22%
Stock Price Statistics The stock price has increased by 2.9% in the
last 52 weeks. The beta is 1.04, so Apollo Medical's
price volatility has been higher than the market average.
Beta 1.04 52-Week Price Change 2.9% 50-Day Moving Average 39.06 200-Day Moving Average 35.15 Relative Strength Index (RSI) 45.15 Average Volume (20 Days) 208,841
Income Statement In the last 12 months, Apollo Medical had revenue of 2.03B
and earned 43.15M
in profits. Earnings per share was 0.91.
Revenue 2.03B Gross Profit n/a Operating Income 89.35M Net Income 43.15M EBITDA 68.86M EBIT n/a Earnings Per Share (EPS) 0.91
Full Income Statement Balance Sheet The company has 158.92M in cash and 35.27M in
debt, giving a net cash position of 123.65M.
Cash & Cash Equivalents 158.92M Total Debt 35.27M Net Cash 123.65M Retained Earnings 286.28M Total Assets 868.29M Working Capital -75.34M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 52.2M
and capital expenditures -8.03M, giving a free cash flow of 44.17M.
Operating Cash Flow 52.2M Capital Expenditures -8.03M Free Cash Flow 44.17M FCF Per Share 0.93
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin 4.39% Pretax Margin 3.97% Profit Margin 2.12% EBITDA Margin 3.38% EBIT Margin 4.39% FCF Margin 2.17%
Dividends & Yields AMEH does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 2.29% FCF Yield 2.34%
Dividend Details Analyst Forecast Currently there are no analyst rating for AMEH.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 17.5 Graham Upside -57.13%
Stock Splits The last stock split was on Apr 27, 2015. It was a
backward
split with a ratio of 1:10.
Last Split Date Apr 27, 2015 Split Type backward Split Ratio 1:10
Scores Altman Z-Score 4.18 Piotroski F-Score 6
